Novacyt investor relations
WebNovacyt Group (UK) Unit 1, Watchmoor Point, Watchmoor Road, Camberley, Surrey GU15 3AD. T +44 (0) 1276 600081. F +44 (0) 1276 600151. E [email protected]. …
Novacyt investor relations
Did you know?
WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the … WebJun 30, 2024 · Novacyt SA Graham Mullis, Chief Executive Officer James McCarthy, Chief Financial Officer +44 (0)1276 600081 SP Angel Corporate Finance LLP (Nominated Adviser and Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470 0470 Numis Securities Limited (Joint Broker)
WebJul 7, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces a trading update for the half year ended 30 June 2024 … WebMay 30, 2024 · See Novacyt funding rounds, investors, investments, exits and more. Evaluate their financials based on Novacyt's post-money valuation and revenue.
WebSolidifying this position, Novacyt was among the first to respond to the COVID-19 pandemic in 2024, providing a rapid and reliable gold standard SARS-CoV-2 test kit that the WHO approved. ... E [email protected]. www.novacyt.com. Registered Address: Novacyt Group (France) 13 Avenue Morane Saulnier 78140. Vélizy-Villacoublay France. WebJun 1, 2024 · Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts …
WebNOVACYT develops cellular diagnostics with a growing portfolio of cancer and infectious disease products and services. Vélizy-villacoublay, Ile-de-France, France 101-250 Post-IPO Debt Public www.novacyt.com/ 35,439 …
WebNovacyt is a leading global diagnostics company. We protect people and society in the fight against infectious diseases by developing tests that accurately detect infections, allowing us to help safeguard people and … iaea secretary generalWebNOVACYT has 8 current employee profiles, including Chief Executive Officer Graham Mullis. Graham Mullis Chief Executive Officer Anthony Dyer Chief Corporate Development Officer Ruth Powell Managing Director of NOVAprep & Lab21 Services Paul Eros Corporate Business Development Director Mandy Cowling Corporate & Investor Relations Manager iaea security glossaryWebNovacyt Group. Jan 2024 - Present5 years 2 months. Cambridge & Camberley. The Corporate & Investor Relations Manager is a multi … mol thermol 32WebMar 22, 2024 · Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology... iaea softwareWebThe Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in … mol. ther.-nucl. acidsWebSep 29, 2024 · Appointed CEO of Novacyt in 2024 Over 25 years of global experience in pharmaceuticals & biopharmaceutical companies Internationally experienced, strategic … iaea short courseWebNOVACYT : Press releases relating to NOVACYT Investor relations London Stock Exchange: NCYT London Stock Exchange iaea srs 109